Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Christopher Curtin

Effects of Rifampin, Cyclosporine A, and Probenecid on the Pharmacokinetic Profile of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Healthy Participants

International Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2015English

Related publications

In Vitro Pharmacological Profile of Ipragliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2019English

Empagliflozin: A New Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

Drugs in Context
Molecular MedicinePharmacology
2014English

Early Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes: Study Based on Continuous Glucose Monitoring

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Retrospective Analysis of Effects of Sodium-Glucose Co-Transporter 2 Inhibitor in Japanese Type 2 Diabetes Mellitus Patients With Chronic Kidney Disease

Diabetes and Vascular Disease Research
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2018English

Sodium-Glucose Co-Transporter-2 Inhibitors in Type 1 Diabetes—a Dangerous Ally

US Endocrinology
EndocrinologyMetabolismDiabetes
2017English

The Long-Term Efficacy of Sodium Glucose Co-Transporter 2 Inhibitor in Patients With Non-Alcoholic Fatty Liver Disease

Internal Medicine
Internal MedicineMedicine
2019English

Sodium‐glucose Co‐transporter Type‐2 Inhibitors: Is the Message Getting Through? A Reply

Anaesthesia
AnesthesiologyPain Medicine
2019English

Assessment of Remogliflozin Etabonate, a Sodium-Dependent Glucose Co-Transporter-2 Inhibitor, as a Perpetrator of Clinical Drug Interactions: A Study on Drug Transporters and Metabolic Enzymes

Journal of Diabetes & Metabolism
2012English

Sodium Glucose Cotransporter 2 Inhibitor Canagliflozin Attenuates Liver Cancer Cell Growth and Angiogenic Activity by Inhibiting Glucose Uptake

International Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy